FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Group |
| Id | Group-375182.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
[No data.]
{
"resourceType": "Group",
"id": "375182",
"meta": {
"versionId": "4",
"lastUpdated": "2025-11-12T15:01:58.374Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"
]
},
"language": "en",
"text": {
"status": "empty",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
"valueMarkdown": "QUARTET USA Trial Control Group [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375182. Revised 2025-11-12. Available at: https://fevir.net/resources/Group/375182. Computable resource at: https://fevir.net/resources/Group/375182#json."
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"name": "Brian S. Alper, MD, MSPH"
}
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/Group/375182",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "375182",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"title": "QUARTET USA Trial Control Group",
"status": "active",
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"useContext": [
{
"code": {
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "evidence-communication",
"display": "Evidence Communication"
},
"valueCodeableConcept": {
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "ComparatorGroup",
"display": "ComparatorGroup"
}
]
}
}
],
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"type": "person",
"membership": "enumerated",
"quantity": 30,
"combinationMethod": "all-of",
"characteristic": [
{
"code": {
"text": "Member of"
},
"valueReference": {
"reference": "Group/372797",
"type": "Group",
"display": "Enrolled Group for QUARTET USA Trial"
},
"exclude": false,
"description": "Enrolled in QUARTET USA Trial"
},
{
"code": {
"text": "Assigned to"
},
"valueReference": {
"reference": "ActivityDefinition/375181",
"type": "ActivityDefinition",
"display": "Candesartan 8 mg once daily"
},
"exclude": false,
"description": "Assigned to Control group (candesartan 8 mg once daily)"
}
]
}